<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109588-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Identification des lacunes dans les connaissances pour la programmation future d&#x2019;une prochaine phase cibl&#xE9;e du programme InnoVet-AMR</narrative>
   <narrative xml:lang="EN">Identifying knowledge gaps for future programming of a targeted next phase of the Innovative Veterinary Solutions for Antimicrobial Resistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Ce projet est soutenu par le programme Solutions v&#xE9;t&#xE9;rinaires innovatrices pour la r&#xE9;sistance aux antimicrobiens (InnoVet-AMR), un partenariat d&#x2019;une valeur de 27,9 millions CAD entre le Department of Health and Social Care (DHSC) du Royaume-Uni et le CRDI. 

Par le biais de cette initiative, le CRDI et le DHSC soutiennent la recherche permettant de d&#xE9;gager des solutions novatrices en m&#xE9;decine v&#xE9;t&#xE9;rinaire, notamment des vaccins, pour r&#xE9;duire l&#x2019;utilisation d&#x2019;antimicrobiens dans les exploitations d&#x2019;&#xE9;levage et d&#x2019;aquaculture dans les pays &#xE0; revenu faible ou interm&#xE9;diaire. InnoVet-AMR &#xE9;tablit &#xE9;galement des partenariats efficaces pour coordonner la d&#xE9;couverte, la mise au point et la distribution durable de ces solutions v&#xE9;t&#xE9;rinaires innovatrices.

Ce projet soutiendra des &#xE9;tudes de cadrage cibl&#xE9;es pour recueillir des donn&#xE9;es fondamentales afin de mieux cibler les futures initiatives de recherche pour le d&#xE9;veloppement qui portent sur la r&#xE9;sistance aux antimicrobiens chez les animaux dans les pays &#xE0; revenu faible ou interm&#xE9;diaire. Les &#xE9;tudes command&#xE9;es identifieront de nouveaux domaines de recherche concernant les technologies innovantes et les produits pr&#xE9;ventifs ou th&#xE9;rapeutiques de remplacement. Les sujets des &#xE9;tudes de cadrage seront s&#xE9;lectionn&#xE9;s apr&#xE8;s une recherche initiale, une discussion avec le groupe de travail InnoVet-AMR et une consultation informelle d&#x2019;experts actuels dans le domaine de la r&#xE9;sistance aux antimicrobiens et d&#x2019;experts locaux bas&#xE9;s dans des pays &#xE0; revenu faible ou interm&#xE9;diaire.</narrative>
   <narrative xml:lang="EN">This project is supported by the Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) program, a CA$27.9 million partnership between the UK&#x2019;s Department of Health and Social Care (DHSC) and IDRC. 

Through this initiative, IDRC and DHSC are supporting research to identify innovative veterinary solutions, including vaccines, to reduce the use of antimicrobials in livestock and aquaculture operations in low- and middle-income countries (LMICs). InnoVet-AMR is also building effective partnerships to coordinate the discovery, development, and sustainable delivery of these innovative veterinary solutions.

This project will support targeted scoping studies to gather fundamental data to better target future research-for-development initiatives on anti-microbial resistance in animals in LMICs. The commissioned studies will identify new areas of research regarding innovative technologies and alternative preventive or therapeutic products. Topics for the scoping studies will be selected following initial research, discussion with the InnoVet-AMR working group, and informal consultation with current experts in the field of anti-microbial resistance and local experts based in LMICs.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="1" type="90">
   <narrative xml:lang="EN">United Kingdom. Department of Health and Social Care</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-01" type="2"></activity-date>
  <activity-date iso-date="2023-04-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31195" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="CAD" value-date="2020-09-29">107050.38</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="CAD" value-date="2020-09-29">142949.62</value>
   <provider-org>
    <narrative xml:lang="EN">United Kingdom. Department of Health and Social Care</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="0"></conditions>
 </iati-activity>
</iati-activities>
